inflammatory response, histopathological changes and apoptosis in the intestine. Glutamine has been shown to reduce bacterial translocation and maintain intestine mucosal integrity, but its effects on the inflammatory response, structural alterations and apoptosis in intestinal mucosa following TBI have not been previously investigated. Using the weight-drop method, a right parietal cortical contusion was induced in rats and, for the next 5 days, they were fed either chow alone or chow mixed with glutamine. Intestinal tissue samples were then removed for analysis. Following TBI, glutamine supplementation was found to: decrease intestinal concentrations of interleukin (IL) -1b, tumour necrosis factor-a (TNF-a) and IL-6; downregulate intercellular adhesion molecule-1 (ICAM-1) expression; attenuate TBI-induced damage to the intestine structure; and reduce apoptosis. These results suggest that post-TBI glutamine administration could suppress intestinal inflammation, protect intestinal mucosal structure and reduce mucosal apoptosis.
Introduction
The importance of the intestinal mucosa in the inflammatory and metabolic responses to sepsis, trauma and other critical illnesses is increasingly recognized. Major trauma and shock may initiate a cascade of intestinal events, such as intestinal cytokine overproduction, 1 increased intestinal permeability, 2 and translocation of intestinal bacteria and endotoxins. 3 These events may not only influence the intestinal mucosa itself, but may also affect the function and integrity of distant organs and tissues, leading to systemic inflammatory response syndrome and multiple organ dysfunction syndrome.
In an earlier study we demonstrated that traumatic brain injury (TBI) could induce marked damage to intestinal mucosa structure, including shedding of epithelial D Feng, W Xu, G Chen et al. Glutamine effects on intestine in traumatic brain injury cells, fracture of villi, focal ulceration, fusion of adjacent villi, dilation of the central chyle duct, mucosal atrophy and the disruption of the tight junction between enterocytes. 4 Since then, we have found that the inflammatory response, mediated by increased proinflammatory cytokines and intercellular adhesion molecule-1 (ICAM-1), could play an important role in the pathogenesis of acute gut mucosal injury following TBI. 5, 6 In a more recent study, we suggested that intestinal mucosa apoptosis was an important mode of cell death that was associated with acute gut damage after TBI. 7 Glutamine, a nonessential amino acid, widely distributed throughout the body, can behave as an essential amino acid in certain clinical settings. Over the past three decades, glutamine studies have been conducted in disorders that are characteristic of significant metabolic stress, and also in post-surgical, septic, critically ill and multiple-trauma patients; studies have also been extended to other situations, such as inflammatory bowel disease, short bowel syndrome and bone marrow transplantation, in which the trophic actions of glutamine on rapidly dividing cells (lymphocytes, mastocytes and enterocytes) could have beneficial effects. 8, 9 Glutamine requirements of the gut are increased in several situations, such as burn injury, major surgery or sepsis. A lack of glutamine promotes mucosal atrophy, an increase in intestinal permeability and bacterial translocation, and a reduced synthesis of glutathione, which is an important factor for antioxidant defence. 10 -14 Several reports from clinical and experimental studies have demonstrated that glutamine had a specific inhibitory effect on the production of proinflammatory cytokines in human gut, 15 attenuated systemic inflammatory response in early post-operative patients, 16 attenuated leucocyte-endothelial cell adhesion, and reduced macroscopic and microcirculatory inflammatory activity in indomethacininduced intestinal inflammation. 17 Historically, the study of glutamine in cellular physiology has focused on its anabolic effects, namely its role as a metabolic precursor and physiological regulator of DNA and protein synthesis in cellular growth. Overt glutamine deprivation ultimately elicits apoptosis by intrinsic and/or extrinsic pathways, depending on cell type. Conversely, an enhanced glutamine supply curbs death receptor-mediated apoptosis in certain cell types, but may actually enhance it in some cancer cells. 18 To date, we have found no study in the literature that has investigated the effects of glutamine on the intestinal inflammatory response and mucosal apoptosis after TBI. As a result, we set out to examine the hypothesis that the effects of glutamine on modulating TBI-induced intestinal pathophysiological changes could provide an attractive target for therapeutic intervention to maintain and improve intestinal function in TBI patients.
Materials and methods

ANIMALS AND PROCEDURES
Male Wistar rats (250 -300 g) were purchased from the Animal Centre of the Chinese Academy of Sciences, Shanghai, China. The rats were housed in temperatureand humidity-controlled animal quarters, with a 12 h light/12 h dark cycle. All procedures were approved by the Institutional Animal Care Committee and were in accordance with the guidelines of the National Institutes of Health on the care and use of animals.
The rat model of cortical contusion trauma was produced by the following method. After intraperitoneal anaesthesia D Feng, W Xu, G Chen et al. Glutamine effects on intestine in traumatic brain injury with 2% sodium pentobarbital in saline (40 mg/kg), the rat's head was fixed in a stereotactic frame. Under aseptic conditions, a right parietal craniotomy (diameter 5 mm) was drilled 1 mm posterior and 2 mm lateral to the bregma. To produce a standardized parietal contusion, a modification of Feeney et al.'s 19 weight-drop model was used, in which a free-falling weight was allowed to fall onto the exposed intact cranial dura. The weight was a steel rod of 40 g with a flat-end diameter of 4 mm that was dropped from a height of 25 cm onto a piston that was resting on the dura. The piston was allowed to compress the tissue a maximum of 5 mm. Afterwards the rats were returned to their cages and room temperature was maintained at 23 ± 1°C. Heart rate, arterial blood pressure and rectal temperatures were monitored throughout the experiment; rectal temperature was maintained at 37 ± 0.5°C by physically cooling (ice bag) when required. Sham-operated rats (n = 6) were anaesthetized, mounted in the stereotaxic apparatus, had their scalps cut and sutured, but did not undergo parietal contusion.
Animals that had received parietal contusion were randomly divided into the following groups: TBI group (n = 6), which was given powdered chow and water for 5 days following TBI; and GTBI group (n = 6), which was given 3% (w/w) glutamine mixed with powdered chow (made up as 3 g glutamine and 97 g powdered chow per 100 g total) and water for 5 days following TBI. The Sham group, was given powdered chow and water following sham operation. Daily food intake and body weight for animals in the three groups were recorded.
For tissue assays, the rats were decapitated 5 days after injury. A 3 cm segment of the mid-ileum was taken and flushed with icecold saline; half was immersed in neutralbuffered formalin for histopathological studies, 1 mm 3 of mucosa was used for ultrastructural observations and the remaining sample was immediately stored in liquid nitrogen for enzyme-linked immunosorbent assay (ELISA).
DETECTION OF IL-1b, TNF-a AND IL-6 IN ILEUM TISSUE
The frozen ileum tissue was homogenized with a glass homogenizer in 1 ml of buffer containing 1 mmol/l phenylmethanesulfonylfluoride, 1 mg/l pepstatin A, 1 mg/l aprotinin and 1 mg/l leupeptin in phosphatebuffered saline solution (pH 7.2), and was then centrifuged at 12 000 g for 20 min at 4°C. The intestinal levels of inflammatory mediators were quantified using specific ELISA kits for rats according to the manufacturers' instructions (TNF-α from Diaclone Research, Besançon, France; IL-1β and IL-6 from Biosource Europe SA, Nivelles, Belgium). Cytokine levels in the ileum tissue were expressed as ng of cytokines per g of protein.
DETECTION OF ICAM-1 EXPRESSION IN ILEUM TISSUE
Immunohistochemical studies were conducted on formalin-fixed, paraffin-embedded sections. The rabbit anti-rat monoclonal antibody of ICAM-1 (diluted 1:100; Santa Cruz Biotechnology Inc., CA, USA) was used. Immunohistochemical assay was performed as described in our previous study. 6 Microscopy of the immunohistochemically stained tissue sections was performed by an experienced pathologist blinded to the experimental treatments. Evaluation of sections was undertaken by visually assessing the intensity of staining on a 0 -4 scale: 0, no detectable positive cells; 1, very low density of positive cells; 2, moderate density of positive cells; 3, higher, but not maximal density of positive cells; and 4, highest density of positive cells.
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HISTOPATHOLOGICAL AND ULTRASTRUCTURAL EXAMINATION
The neutral-buffered formalin-fixed ileum was embedded in paraffin, sectioned at 4 µm thickness with a microtome, stained with hematoxylin and eosin, and examined under a light microscope. Villous height, middle villous segment diameter and crypt depth in all tissues were determined using the HPIAS-1000 colour image analysis system (Champion Image Engineering Company, Wuhan, China). Villous surface area was calculated according to the following formula: surface area = πdh (d, diameter; h, villous height). At least 10 welloriented crypt-villous units per small intestinal sample were measured and averaged by a pathologist who was blinded to the animal groups.
Samples for electron microscopy were fixed in phosphate-buffered glutaraldehyde (2.5%) and osmium tetroxide (1%). Dehydration of the mucosa was accomplished in acetone solutions of increasing concentration. The tissue was embedded in an epoxy resin. Sections (1 µm) through the mucosa were then made and stained with toluidine blue. Then 600 Å thick sections were made from selected areas of these 1 µm sections and stained with lead citrate and uranyl acetate. The ultrastructure of the mucosa was observed using a transmission electron microscope (JEM-1200X; JEOL, Tokyo, Japan).
TUNEL STAINING AND QUANTITATION OF APOPTOTIC CELLS
Formalin-fixed tissues were embedded in paraffin and sectioned at 4 µm thickness with a microtome. Apoptotic cells were detected in the sections by the terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling (TUNEL) method using a TUNEL: In situ Cell Death Detection Kit, POD (ISCDD, Boehringer Mannheim, Mannheim, Germany) and following procedures according to the protocol of the kit and our previous study. 7 Microscopy of the stained tissue sections was performed by a pathologist who was blinded to the experimental treatments. Ten villi and crypts for each section were observed under 100× magnification and the average number of apoptotic cells in 100 counted cells was assigned as the apoptotic index. The distinctive morphological features of apoptosis were used to recognize apoptotic cells. Small clusters of dead cell fragments were assessed as originating from one cell and given a single count and any doubtful cells were disregarded.
STATISTICAL ANALYSES
All data were presented as mean ± SD. Statistical analyses were performed using the Statistical Package for Social Sciences (SPSS ® version 12.0; SPSS Inc., Chicago, IL, USA). Comparisons of ICAM-1 grades among groups were conducted using the Mann-Whitney U-test. The other measurements were analysed by one-way analysis of variance, followed by the Tukey post hoc test. P-values < 0.05 were considered to be statistically significant.
Results
GENERAL OBSERVATIONS
Body weight and daily food intake of animals in the three groups are shown in Table 1 .
Rats in the Sham group usually recovered consciousness during the 3 h period after anaesthesia and sham operation, whereas rats in both the TBI and GTBI groups were temporally unconscious for 12 h post-injury and recovered almost normal eating behaviour from 18 h after cortical contusion D Feng, W Xu, G Chen et al. Glutamine effects on intestine in traumatic brain injury trauma.
During the period of unconsciousness, rats were given 2 ml of water per 3 h by tube feeding. After right parietal cortical contusion, rats failed to extend fully the left forepaw. Mean arterial blood pressure values and body temperature were within the normal physiological range for all animals (data not shown).
INTESTINAL LEVELS OF INFLAMMATORY CYTOKINES
Concentrations of IL-1β, TNF-α and IL-6 for each of the three groups are shown in Fig. 1 and were lowest in the gut of rats in the Sham group (2.01 ± 0.53, 1.89 ± 0.40 and 5.08 ± 1.43 ng/g protein, respectively). Compared with the Sham group, intestinal levels of the three inflammatory cytokines were all significantly increased after TBI (P < 0.01). Glutamine administration after TBI (GTBI group) led to significant decreases in IL-1β, TNF-α and IL-6 concentrations compared with the TBI group that did not receive glutamine (P < 0.01, P < 0.05, P < 0.05, respectively).
EXPRESSION OF ICAM-1 IN ILEUM TISSUE
The immunohistochemical assay showed low ICAM-1 immunoreactivity in the lamina propia of the mucosa and interstitial region in the Sham group (Figs 2A and 2D) .
Compared with the Sham group, ICAM-1 was significantly upregulated (P < 0.01) in the villous interstitium and lamina propria of the TBI group (Figs 2B and 2D ). In the GTBI group, ICAM-1 immunoreactivity was significantly decreased compared with the TBI group (P < 0.05) ( Figs 2C and 2D) , indicating that glutamine supplementation could significantly downregulate the ICAM-1 immunoreactivity in rat intestine following TBI (Fig. 2D ).
HISTOMORPHOMETRIC STUDIES
Villous height, villous diameter, crypt depth and villous surface area were determined as specific indices for the evaluation of mucosal damage. Quantitative analyses of the villi demonstrated that villous height, crypt depth and villous surface area were significantly decreased in the TBI group compared with the Sham group (P < 0.01, P < 0.01 and P < 0.05, respectively) ( Table 2 ). In the GTBI group, villous height and crypt depth were increased significantly compared with the TBI group (P < 0.05).
ULTRASTRUCTURE OBSERVATIONS
The structure of microvilli was well arranged and shaped in the Sham group (Fig. 3A) . In the TBI group, obvious ultrastructural alterations were found, including ruptured, 
TABLE 1: Body weights and daily food intake of rats with traumatic brain injury (TBI) fed for 5 days with chow alone (TBI group, n = 6) or chow plus glutamine (GTBI group, n = 6), and of sham operation rats without TBI and fed chow alone (Sham group, n = 6)
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APOPTOSIS IN INTESTINAL MUSCOSAL EPITHELIUM
Few TUNEL-positive apoptotic cells were found in the intestines of the Sham group (Figs 4A and 4D) . The number of TUNELpositive apoptotic cells in the ileum tissue of the TBI group was significantly increased compared with the Sham group (P < 0.01) ( Figs 4B and 4D ). In the GTBI group the number of apoptotic cells was significantly decreased compared with the TBI group (P < 0.05) ( Figs 4C and 4D) , indicating that glutamine administration could inhibit apoptotic cell death in the gut and had the potential to reduce gut damage following TBI (Fig. 4D ).
Discussion
The main findings of this study were: (i) the inflammatory response in the intestine was upregulated after TBI and could be suppressed when treated with glutamine; (ii) glutamine supplementation could attenuate TBI-induced damage to gut structure; and (iii) after glutamine administration, the number of TUNEL-positive apoptotic cells in the intestines was significantly decreased. These findings suggest for the first time that glutamine may suppress intestinal inflammation, protect intestinal mucosal structure and reduce mucosa apoptosis in a rat TBI model.
The major changes of gastrointestinal function after TBI may be classified into four aspects: stress ulcer, gut motility dysfunction, disruption of gut barrier and alteration of mucosal absorptive function. Previously, we reported that TBI could lead to significant damage to gut structure and impairment of barrier function. 4 The intestine is the largest immune organ of the body and is a major nidus for inflammation that can spread to the entire body, causing systemic inflammation. The intestinal inflammatory response following trauma is characterized by intestinal recruitment of neutrophils and monocytes through release of proinflammatory cytokines and the upregulation of adhesion molecules, which can lead to gut mucosal injury. 5, 6 Our previous study also definitely proved that marked apoptosis of intestinal epithelial cells occurred after TBI, and it was probably a cause of acute intestinal mucosal injury. There is still no effective treatment, however, for gut injury caused by TBI. 7 Glutamine is the most abundant free amino acid in the circulatory system, accounting for 30 -35% of all amino acids. It is also well known to reduce bacterial translocation and to maintain gut mucosal integrity. 20 -22 During periods of critical illness, glutamine is freely released from skeletal muscle and intracellular glutamine concentrations fall by more than 50%. 23, 24 Individuals deficient in glutamine exhibit changes in gut morphology, including increased membrane permeability resulting in bacterial translocation, malabsorption and diarrhoea. Although the body can synthesize glutamine, it is currently considered to be a conditionally essential amino acid during periods of catabolism. Glutamine synthesis, however, cannot keep up with increased requirements during stress so supplemental glutamine is needed to maintain gut integrity, provide fuel for cells with rapid turnover and improve overall nitrogen balance, especially for critically ill patients.
Previous literature has examined the role of glutamine in regulating the immune response. 25 -27 In trauma patients, glutamine supplementation resulted in decreased pneumonia and sepsis, and prevented the elevation of proinflammatory cytokines involved in systemic inflammatory response D Feng, W Xu, G Chen et al. Glutamine effects on intestine in traumatic brain injury syndrome. 28 In rats with lipopolysaccharide-induced intestinal inflammation, a supplement of glutamine decreased intestinal and plasma TNF-α. 29 Studies in human volunteers have shown that glutamine decreases IL-6 in the intestine. 30 Our study has shown that intestinal TNF-α, IL-1β and IL-6 levels were significantly induced by TBI 5 days after trauma and that glutamine administration following TBI could downregulate the expression of these proinflammatory cytokines. ICAM-1, a member of the immunoglobulin super-family of adhesion molecules, is important in leucocyte recruitment during the inflammatory process and could have a profound effect when upregulated after cytokine challenge. Aosasa et al. 31 studied the effect of glutamine supplementation on ICAM-1 expression in vitro and found that 10 mmol/l glutamine supplementation of the culture media caused enterocytes to display a decrease in ICAM-1 expression. In an ischaemia/reperfusion mouse model, total parenteral nutrition supplementation with glutamine reduced intestinal ICAM-1 expression and improved survival. 32 The current study demonstrates that oral glutamine administration could significantly suppress ICAM-1 immunoreactivity in rat intestine following TBI. Although our data show that glutamine could downregulate the intestinal inflammatory cytokines and ICAM-1 after TBI, the changes that occur in the inflammatory signalling pathway in the gut remain unknown. Further studies are required and will be conducted in our laboratory.
A number of in vitro studies have examined the role of glutamine in preventing apoptosis following stress or injury. 33, 34 One study of note by Evans et al., 33 indicated that glutamine can prevent intestinal cell apoptosis via the pyrimidine pathway. This provides an interesting mechanistic explanation for the benefits of glutamine. Another interesting study demonstrated that oral glutamine could prevent increases in gut apoptosis and gut permeability in rats with obstructive jaundice. 35 In this present study, we found that glutamine supplementation could inhibit apoptotic cell death in the gut and has the potential to reduce gut damage following TBI. Glutamine deprivation may activate caspase-3 as a mechanism directly eliciting intrinsic apoptosis in enterocytes, 36 and glutamine limitation has been shown to modulate apoptosis via the extrinsic (death receptor) pathway. 37 The mechanisms of anti-apoptosis are not well known, however, and it is still unclear whether glutamine can modulate the apoptotic signals; all of the mechanisms involved call for further research.
In summary, to the best of our knowledge, this is the first study to demonstrate the effects of glutamine on TBI-induced intestinal pathophysiological changes. We found that glutamine supplementation could suppress TBI-induced inflammation of the gut, protect ileum mucosa structure and reduce intestinal apoptosis. These results suggest that the therapeutic benefit of post-TBI glutamine oral administration might be due to its salutary effect on modulating intestinal inflammatory response and apoptosis.
